動物モデルの世界市場

動物モデルの世界市場は2030年までに37億米ドルに達する

2024年に24億米ドルと推定される動物モデルの世界市場は、2024年から2030年にかけてCAGR 7.4％で成長し、2030年には37億米ドルに達すると予測されます。本レポートで分析されているセグメントの1つであるマウスは、CAGR 8.8%を記録し、分析期間終了時には12億米ドルに達すると予測されています。ラットセグメントの成長率は、分析期間でCAGR 7.5％と推定されます。

米国市場は6億5,460万米ドルと推定、中国はCAGR11.8％で成長予測

米国の動物モデル市場は2024年に6億5,460万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを11.8%として、2030年までに7億8,830万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7%と7.2%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の動物モデル市場- 主要動向と促進要因まとめ

なぜ生物医学研究において動物モデルの需要が高まっているのか？

生物医学および製薬研究における動物モデルへの依存の高まりは、市場成長の主な促進要因です。がん、糖尿病、神経変性疾患などの慢性疾患の有病率が上昇を続ける中、新しい治療薬の安全性と有効性を評価するための前臨床試験の必要性が高まっています。動物モデルは、ヒトの生理・病理を忠実に模倣した生物学的システムを提供することにより、トランスレーショナルリサーチにおいて重要な役割を果たし、研究者は疾病メカニズムに関する重要な洞察を得ることができます。個別化医療と遺伝子治療への注目の高まりは、特定のヒトの遺伝的状態をシミュレートできる遺伝子改変動物モデルへの需要をさらに加速させています。さらに、FDAやEMAのような規制機関は、ヒト試験用の医薬品を承認する前に、動物モデルを用いた前臨床試験を義務付けており、医薬品開発パイプラインにおける動物モデルの重要性をさらに高めています。

技術の進歩はどのように動物モデル市場を形成しているか？

遺伝子工学とバイオテクノロジーにおける技術革新は、研究用途のより精密で信頼性の高い動物モデルの開発に革命をもたらしています。CRISPR-Cas9遺伝子編集技術の開発により、特異性の高い遺伝子改変動物モデルの作製が可能になり、研究者は疾患の発生や進行における特定の遺伝子の役割を研究できるようになりました。動物研究における人工知能（AI）とデータ解析の統合も、生理学的・行動学的反応の自動追跡を可能にすることで、調査の精度を向上させています。さらに、3Dバイオプリンティングや臓器オンチップ技術の採用が進むことで、従来の動物モデルが補完され、より正確で倫理的に責任のある研究を実施する能力が高まっています。こうした技術の進歩は、前臨床研究の再現性と信頼性を向上させるだけでなく、再生医療や毒性試験における新たな可能性をも開いています。

動物モデル市場に存在する課題と機会とは？

動物モデル市場は、倫理的懸念、規制当局の監視、代替試験法の利用可能性など、いくつかの課題に直面しています。研究における動物の使用をめぐる倫理的議論は、厳しいガイドラインや動物愛護団体からの圧力の高まりにつながり、業界は試験管内モデルやコンピュータシミュレーションなど、動物以外の代替手段を模索するようになりました。規制機関は動物福祉に関するコンプライアンス要件を厳しくしており、製薬・研究機関の市場情勢をさらに複雑にしています。しかし、このような課題は、市場関係者にとっては、研究成果を最大化しつつ苦痛を最小限に抑える、より洗練された人道的な動物モデルを開発するチャンスでもあります。ヒトの病態をよりよく再現するためにヒトの細胞や遺伝子を組み込んだヒト化動物モデルの採用が増加していることも、腫瘍学、免疫学、感染症の研究に新たな道を開いています。

動物モデル市場の成長を促進する主な要因は？

動物モデル市場の成長は、新規治療薬に対する需要の高まり、生物医学研究に対する政府資金の拡大、動物モデルベースの調査を必要とする人獣共通感染症の蔓延の増加など、いくつかの要因によって牽引されています。製薬会社は革新的な医薬品や生物製剤を開発するために前臨床研究に多額の投資を行っており、信頼性の高い有効性と安全性のデータを提供できる高度な動物モデルに対する需要を煽っています。特に新興感染症や世界の健康脅威を考慮したワクチン開発への注目の高まりが、市場をさらに押し上げています。さらに、家畜の生産性とコンパニオンアニマルの健康を向上させるための獣医学研究における動物モデルの使用の増加が、市場の拡大に寄与しています。遺伝子工学と分子生物学の絶え間ない進歩により、動物モデル市場は持続的な成長を遂げ、世界中の研究機関や業界の利害関係者に新たな機会を提供しています。

セグメント

動物タイプ（マウス、ラット、モルモット、ハムスター、その他の動物タイプ）;用途（がん用途、感染症用途、免疫疾患用途、その他の用途）;最終用途（製薬・バイオテクノロジー企業、受託研究機関、学術研究機関）

調査対象企業の例

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway S.A.
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Animal Model Market to Reach US$3.7 Billion by 2030

The global market for Animal Model estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Mice, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Rat segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$654.6 Million While China is Forecast to Grow at 11.8% CAGR

The Animal Model market in the U.S. is estimated at US$654.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$788.3 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Animal Model Market - Key Trends & Drivers Summarized

Why Is the Demand for Animal Models Rising in Biomedical Research?

The growing reliance on animal models in biomedical and pharmaceutical research is a key driver of market growth. As the prevalence of chronic diseases such as cancer, diabetes, and neurodegenerative disorders continues to rise, there is an increasing need for preclinical studies to evaluate the safety and efficacy of new therapeutics. Animal models play a crucial role in translational research by providing a biological system that closely mimics human physiology and pathology, allowing researchers to gain critical insights into disease mechanisms. The expanding focus on personalized medicine and gene therapy has further accelerated demand for genetically modified animal models that can simulate specific human genetic conditions. Additionally, regulatory bodies such as the FDA and EMA mandate preclinical testing using animal models before approving drugs for human trials, further cementing their importance in the drug development pipeline.

How Are Technological Advancements Shaping the Animal Model Market?

Innovations in genetic engineering and biotechnology are revolutionizing the development of more precise and reliable animal models for research applications. Advances in CRISPR-Cas9 gene-editing technology have enabled the creation of genetically modified animal models with high specificity, allowing researchers to study the role of specific genes in disease development and progression. The integration of artificial intelligence (AI) and data analytics in animal research is also improving study accuracy by enabling the automated tracking of physiological and behavioral responses. Furthermore, the increasing adoption of 3D bioprinting and organ-on-chip technologies is complementing traditional animal models, enhancing the ability to conduct more accurate and ethically responsible research. These technological advancements are not only improving the reproducibility and reliability of preclinical studies but are also opening up new opportunities in regenerative medicine and toxicology testing.

What Challenges and Opportunities Exist in the Animal Model Market?

The animal model market faces several challenges, including ethical concerns, regulatory scrutiny, and the availability of alternative testing methods. Ethical debates surrounding the use of animals in research have led to stringent guidelines and increased pressure from animal rights organizations, prompting the industry to explore non-animal alternatives such as in vitro models and computer simulations. Regulatory agencies are imposing stricter compliance requirements related to animal welfare, further complicating the market landscape for pharmaceutical and research institutions. However, these challenges present opportunities for market players to develop more refined and humane animal models that minimize suffering while maximizing research outcomes. The increasing adoption of humanized animal models, which incorporate human cells or genes to better replicate human conditions, is also opening new avenues for research in oncology, immunology, and infectious diseases.

What Are the Key Factors Driving Growth in the Animal Model Market?

The growth in the Animal Model market is driven by several factors, including the rising demand for novel therapeutics, expanding government funding for biomedical research, and the increasing prevalence of zoonotic diseases that require animal model-based studies. Pharmaceutical companies are investing heavily in preclinical research to develop innovative drugs and biologics, fueling demand for sophisticated animal models that can provide reliable efficacy and safety data. The growing focus on vaccine development, particularly in light of emerging infectious diseases and global health threats, is further boosting the market. Additionally, the rising use of animal models in veterinary research to improve livestock productivity and companion animal health is contributing to market expansion. With continuous advancements in genetic engineering and molecular biology, the animal model market is poised for sustained growth, offering new opportunities for research institutions and industry stakeholders worldwide.

SCOPE OF STUDY:

The report analyzes the Animal Model market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Mice, Rat, Guinea Pig, Hamster, Other Animal Types); Application (Cancer Application, Infectious Disease Application, Immunological disease Application, Other Applications); End-Use (Pharma and Biotech Companies End-Use, Contract Research Organizations End-Use, Academic Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway S.A.
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Animal Model - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Preclinical Research in Drug Development Drives the Growth of Animal Model Usage
  • Technological Advancements in Genetic Engineering Enhance the Precision and Reliability of Animal Models
  • Increasing Regulatory Requirements for Drug Safety and Efficacy Strengthen the Business Case for Animal Models
  • Expansion of Biopharmaceutical and Biotechnology Industries Spurs Demand for Advanced Animal Model Testing
  • Growing Emphasis on Personalized Medicine Fuels Demand for Genetically Modified and Humanized Animal Models
  • Rising Prevalence of Chronic Diseases Encourages the Use of Animal Models in Biomedical Research
  • Ethical Concerns and Alternative Testing Methods Present Challenges and Opportunities for Market Innovation
  • Collaborations Between Academic Institutions and Pharmaceutical Companies Drive New Developments in Animal Model Research
  • Increasing Government and Private Funding for Life Sciences Research Boosts Market Growth for Animal Models
  • Emergence of Alternative 3D Culture Systems and In-Vitro Models Pose Competitive Challenges for Animal Testing
  • Expansion of Cancer Research and Oncology Studies Strengthens Demand for Rodent-Based Animal Models
  • Rising Use of Large Animal Models in Regenerative Medicine Research Enhances Market Potential
  • Technological Innovations in Imaging and Monitoring Systems Improve the Efficiency of Animal Model Studies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Animal Model Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Mice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Rat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Guinea Pig by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hamster by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Immunological disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION